PD-1 knockout tumor-infiltrating lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 knockout tumor-infiltrating lymphocytes, covering 2025-06-24 to 2025-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer [Phase 1]